Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 37651 - 37675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	LACTB	114294	upregulated	entinostat results in increased expression of LACTB mRNA	15q22.2	A21037 A21035
Entinostat	Investigational	LAMC1	3915	upregulated	entinostat results in increased expression of LAMC1 mRNA	1q25.3	A21035
Entinostat	Investigational	LAMC3	10319	upregulated	entinostat results in increased expression of LAMC3 mRNA	9q34.12	A21037
Entinostat	Investigational	LAMP2	3920	upregulated	entinostat results in increased expression of LAMP2 mRNA	Xq24	A21037
Entinostat	Investigational	LAMP3	27074	upregulated	entinostat results in increased expression of LAMP3 mRNA	3q27.1	A21035
Entinostat	Investigational	LANCL2	55915	downregulated	entinostat results in decreased expression of LANCL2 mRNA	7p11.2	A21035
Entinostat	Investigational	LARP4	113251	upregulated	entinostat results in increased expression of LARP4 mRNA	12q13.12	A21037
Entinostat	Investigational	LARP7	51574	upregulated	entinostat results in increased expression of LARP7 mRNA	4q25	A21037
Entinostat	Investigational	LAYN	143903	upregulated	entinostat results in increased expression of LAYN mRNA	11q23.1	A21037 A21035
Entinostat	Investigational	LCA5	167691	downregulated	entinostat results in decreased expression of LCA5 mRNA	6q14.1	A21037
Entinostat	Investigational	LCK	3932	upregulated	entinostat results in increased expression of LCK mRNA	1p35.2	A21037
Entinostat	Investigational	LCORL	254251	downregulated	entinostat results in decreased expression of LCORL mRNA	4p15.31	A21035
Entinostat	Investigational	LCTL	197021	downregulated	entinostat results in decreased expression of LCTL mRNA	15q22.31	A21037
Entinostat	Investigational	LDHD	197257	upregulated	entinostat results in increased expression of LDHD mRNA	16q23.1	A21037
Entinostat	Investigational	LDLRAP1	26119	upregulated	entinostat results in increased expression of LDLRAP1 mRNA	1p36.11	A21037 A21035
Entinostat	Investigational	LEF1	51176	upregulated	entinostat results in increased expression of LEF1 mRNA	4q25	A21035
Entinostat	Investigational	LEMD1	93273	downregulated	entinostat results in decreased expression of LEMD1 mRNA	1q32.1	A21037
Entinostat	Investigational	LGALS1	3956	upregulated	entinostat results in increased expression of LGALS1 mRNA	22q13.1	A21035
Entinostat	Investigational	LGALS3	3958	upregulated	entinostat results in increased expression of LGALS3 mRNA	14q22.3	A21037
Entinostat	Investigational	LGALS7B	653499	upregulated	entinostat results in increased expression of LGALS7B mRNA	19q13.2	A21037
Entinostat	Investigational	LGR5	8549	downregulated	entinostat results in decreased expression of LGR5 mRNA	12q21.1	A21037
Entinostat	Investigational	LHFP	10186	upregulated	entinostat results in increased expression of LHFP mRNA	13q13.3-q14.11	A21037
Entinostat	Investigational	LHX2	9355	downregulated	entinostat results in decreased expression of LHX2 mRNA	9q33.3	A21037
Entinostat	Investigational	LHX4	89884	upregulated	entinostat results in increased expression of LHX4 mRNA	1q25.2	A21037
Entinostat	Investigational	LHX8	431707	upregulated	entinostat results in increased expression of LHX8 mRNA	1p31.1	A21037

Displaying entries 37651 - 37675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability